You have 3 free searches left this month | for more free features.

Condition

Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers (1)

Breast Cancer (1)

Cancer of Head and Neck (1)

Renal Cell Carcinoma (1)

Solid Tumor (1)

Overall Status

Completed (3)

Sign in for free

Phase

phase 1 (2)

phase 2 (1)

Sponsor

Hoffmann-La Roche (3)

Collaborator

Intervention

ro6874281 (2)

atezolizumab (1)

atezolizumab (mpdl3280a), an engineered anti-pd-l1 antibody (1)

bevacizumab (1)

cetuximab (1)

gemcitabine (1)

simlukafusp alfa (1)

trastuzumab (1)

vinorelbine (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

RO6874281

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Solid Tumor, Breast Cancer, Cancer of Head and Neck Trial in Worldwide (RO6874281, Trastuzumab, Cetuximab)

Completed

Solid Tumor
+2 more

RO6874281
+2 more

Tucson, Arizona
+25 more

Nov 21, 2022

Renal Cell Carcinoma Trial in Worldwide (Atezolizumab, Bevacizumab, RO6874281)

Completed

Renal Cell Carcinoma

Atezolizumab
+2 more

New Haven, Connecticut
+22 more

Sep 10, 2021

Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers Trial in Worldwide (simlukafusp alfa, Atezolizumab

Completed

Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers

simlukafusp alfa
+3 more

San Francisco, California
+43 more

Feb 18, 2022